We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (βNGM Bioβ) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative...
SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative...
--Enrollment ongoing for patients with microsatellite stability (MSS) colorectal cancer (CRC) in Phase1/2 trial of NGM707, a dual ILT2/ILT4 antagonist antibody product candidate, in combination...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | -0.05 | -3.14465408805 | 1.59 | 1.6 | 1.54 | 1121628 | 1.55338426 | CS |
12 | 0.01 | 0.653594771242 | 1.53 | 2.2 | 1.345 | 1097160 | 1.58419517 | CS |
26 | 0.665 | 76 | 0.875 | 2.2 | 0.6002 | 1002158 | 1.33326651 | CS |
52 | -2.39 | -60.8142493639 | 3.93 | 4.69 | 0.6002 | 675608 | 1.60141499 | CS |
156 | -25.61 | -94.3278084715 | 27.15 | 30.13 | 0.6002 | 517339 | 8.03407993 | CS |
260 | -13.86 | -90 | 15.4 | 32.12 | 0.6002 | 397183 | 10.71287688 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions